Serum Paraoxonase-1 and Atherosclerotic Cardiovascular Disease
Authors:
Open Access
- 20 December 2024
- journal article
- review article
- Published by Czech Society of Cardiology in Cor et Vasa
- Vol. 66 (6) , 608-614
Abstract
D?ky sv?mu um?st?n? chr?n? hydrofobn? lipidov? dom?na paraoxon?zy-1 (PON-1) lipoproteiny o vysok? hustot? (high-density lipoprotein, HDL), lipoproteiny o n?zk? hustot? (low-density lipoprotein, LDL) a bun??n? membr?ny na vn?j?? stran? p?ed oxi...Keywords
This publication has 53 references indexed in Scilit:
- PON1 lactonase activity and its association with cardiovascular diseaseClinica Chimica Acta, 2020
- Paraoxonase and atherosclerosis-related cardiovascular diseasesBiochimie, 2017
- Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studiesAtherosclerosis, 2016
- Paraoxonase 1: A better atherosclerotic risk predictor than HDL in type 2 diabetes mellitusDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2013
- Cholesteryl-ester transfer protein enhances the ability of high-density lipoprotein to inhibit low-density lipoprotein oxidationIUBMB Life, 2011
- Structural characterization of the catalytic calcium-binding site in diisopropyl fluorophosphatase (DFPase)—Comparison with related β-propeller enzymesChemico-Biological Interactions, 2010
- The Effect of HDL Mimetic Peptide 4F on PON12009
- Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitroAtherosclerosis, 2009
- Relationship of Paraoxonase 1 (PON1) Gene Polymorphisms and Functional Activity With Systemic Oxidative Stress and Cardiovascular RiskJAMA, 2008
- Oxidative inactivation of paraoxonase—implications in diabetes mellitus and atherosclerosisBiochimica et Biophysica Acta (BBA) - General Subjects, 2005